Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06068153
Title AMG510 (Sotorasib) Plus Lenvatinib as Second-line Treatment in Patients With KRASG12C Mutant, Metastatic NSCLC (AMBER)
Acronym AMBER
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors ETOP IBCSG Partners Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP | DEU | AUT

Facility Status City State Zip Country Details
Medical University of Innsbruck / UK für Innere Medizin V Innsbruck Austria Details
University Hospital of Munich (LMU), Department of Medicine V (Pneumology/Thoracic Oncology) Munich Germany Details
Alicante University Dr Balmis Hospital ISABIAL Alicante Spain Details
Ico Badalona - Hospital Germans Trias I Pujol Badalona Spain Details
Hospital Universitario Lucus Augusti Lugo Spain Details
Hospital Universitario de Salamanca Salamanca Spain Details
Hospital Universitario Nuestra Señora de Candelaria Santa Cruz De Tenerife Spain Details
Hospital Universitario Virgen Del Rocio Sevilla Spain Details
Hospital Universitario de Toledo Toledo Spain Details
Hospital Universitario Y Politécnico La Fe Valencia Spain Details
Istituto Oncologico della Svizzera Italiana Bellinzona Switzerland Details
Kantonsspital Graubünden Chur Switzerland Details
HFR Fribourg Fribourg Switzerland Details
HUG Geneva Switzerland Details
Kantonsspital Winterthur Winterthur Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field